In Vivo Trafficking of the Anticancer Drug Tris by Gallium-68/67 PET/SPECT Imaging

• Published in: Molecules (Basel, Switzerland) Vol. 28; no. 20
• Main Authors: Darwesh, Afnan M. F, Imbe, Bartnicka, Joanna J, Al-Salemee, Fahad, Blower, Julia E, Rigby, Alex, Bordoloi, Jayanta, Griffiths, Alex, Ma, Michelle T, Blower, Philip J
• Format: Journal Article
• Language: English
• Published: MDPI AG 01.10.2023
• Subjects: Antimitotic agents; Antineoplastic agents; Drug dealing; Drug traffic; Gastrointestinal system; Lymphomas; Measurement; Radiation; SPECT imaging; United Kingdom
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules28207217

KP46 (tris(hydroxyquinolinato)gallium(III)) is an experimental, orally administered anticancer drug. Its absorption, delivery to tumours, and mode of action are poorly understood. We aimed to gain insight into these issues using gallium-67 and gallium-68 as radiotracers with SPECT and PET imaging in mice. [[sup.67]Ga]KP46 and [[sup.68]Ga]KP46, compared with [[sup.68]Ga]gallium acetate, were used for logP measurements, in vitro cell uptake studies in A375 melanoma cells, and in vivo imaging in mice bearing A375 tumour xenografts up to 48 h after intravenous (tracer level) and oral (tracer and bulk) administration. [sup.68]Ga was more efficiently accumulated in A375 cells in vitro when presented as [[sup.68]Ga]KP46 than as [[sup.68]Ga]gallium acetate, but the reverse was observed when intravenously administered in vivo. After oral administration of [[sup.68/67]Ga]KP46, absorption of [sup.68]Ga and [sup.67]Ga from the GI tract and delivery to tumours were poor, with the majority excreted in faeces. By 48 h, low but measurable amounts were accumulated in tumours. The distribution in tissues of absorbed radiogallium and octanol extraction of tissues suggested trafficking as free gallium rather than as KP46. We conclude that KP46 likely acts as a slow releaser of gallium ions which are inefficiently absorbed from the GI tract and trafficked to tissues, including tumour and bone.